REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 4.00 (7.55%)
Spread: 2.00 (3.571%)
Open: 53.50
High: 57.00
Low: 56.00
Prev. Close: 53.00
CLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options

14 Feb 2024 13:08

RNS Number : 1572D
Calnex Solutions PLC
14 February 2024
 

Calnex Solutions plc

 

("Calnex" or the "Company")

 

Exercise of Options

 

Calnex Solutions plc (AIM: CLX), a leading provider of test and measurement solutions for the global telecommunications and cloud computing markets, announces that the Company has issued a total of 16,667 new ordinary shares of 0.125 pence each ("New Shares"), pursuant to the exercise of options issued under the Company's EMI Share Option Plan.

 

Application will be made for the admission of the New Shares to trading on AIM ("Admission"). The New Shares will rank pari passu with the existing Ordinary Shares and it is expected that Admission will become effective at 8.00 a.m. on 16 February 2024.

 

Following Admission, the Company's issued share capital will consist of 87,540,602 Ordinary Shares with voting rights. Calnex does not hold any Ordinary Shares in treasury. This figure of 87,540,602 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they require to notify their interest in, or a change to their interest in, the share capital of the Company under the UK Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

For more information, please contact:

Calnex Solutions plc

Via Alma

Tommy Cook, Chief Executive Officer

Ashleigh Greenan, Chief Financial Officer

Cavendish Capital Markets Limited - NOMAD

+44 (0)131 220 6939

Derrick Lee, Peter Lynch

 

Alma

+44(0) 20 3405 0213

Caroline Forde, Hannah Campbell, Joe Pederzolli

 

Overview of Calnex

Calnex Solutions designs, produces and markets test and measurement instrumentation and solutions for the telecommunications and cloud computing industries. Calnex's portfolio enables R&D, pre-deployment and in-service testing for network technologies and networked applications, enabling its customers to validate the performance of the critical infrastructure associated with telecommunications and cloud computing networks and the applications that run on it.

 

To date, Calnex has secured and delivered orders in 68 countries across the world. Customers include BT, China Mobile, NTT, Ericsson, Nokia, Intel, Qualcomm, IBM and Meta.

 

Founded in 2006, Calnex is headquartered in Linlithgow, Scotland, with additional locations in Belfast, Northern Ireland, Stevenage, England and California in the US, supported by sales teams in China and India. Calnex has a global network of partners, providing a worldwide distribution capability. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOETIMJTMTMBBFI
Date   Source Headline
6th May 20227:00 amRNSNotice of Investor Presentation
26th Apr 20229:13 amRNSAward of Options
22nd Apr 202210:50 amRNSHolding(s) in Company
21st Apr 20223:37 pmRNSPDMR Dealing
21st Apr 20227:00 amRNSCalnex receives two Queen’s awards for Enterprise
12th Apr 20227:00 amRNSAcquisition of iTrinegy and Update on Trading
1st Mar 20227:00 amRNSTrading Update
25th Jan 202210:00 amRNSDirector Dealing
11th Jan 20227:00 amRNSBoard Appointments
29th Nov 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20219:55 amRNSHolding(s) in Company
23rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
23rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
23rd Nov 20212:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInterim Results
10th Nov 20217:00 amRNSNotice of Results and Investor Presentation
3rd Nov 202111:03 amRNSHolding(s) in Company
15th Oct 20219:33 amRNSPDMR Dealing
12th Oct 20217:00 amRNSTrading Update
7th Sep 20217:00 amRNSAward of Options
19th Aug 20215:05 pmRNSResult of AGM
19th Aug 20217:00 amRNSAGM Statement
4th Aug 20214:34 pmRNSHolding(s) in Company
15th Jul 20212:53 pmRNSDirector Dealing
28th Jun 20217:00 amRNSNotice of AGM and Posting of Annual Report
16th Jun 20214:26 pmRNSPDMR Dealing
25th May 20217:00 amRNSFY21 Final Results
17th May 20217:00 amRNSNotice of Results and Investor Presentation
15th Apr 202112:31 pmRNSPDMR Shareholding
1st Apr 20214:05 pmRNSPDMR/PCA Dealing
24th Mar 20214:14 pmRNSPDMR Dealing
16th Feb 20217:00 amRNSTrading Update
1st Feb 20213:53 pmRNSPDMR Dealing
10th Dec 20202:05 pmRNSSecond Price Monitoring Extn
10th Dec 20202:00 pmRNSPrice Monitoring Extension
25th Nov 202011:05 amRNSSecond Price Monitoring Extn
25th Nov 202011:00 amRNSPrice Monitoring Extension
25th Nov 20209:00 amRNSPrice Monitoring Extension
25th Nov 20207:00 amRNSInterim Results
23rd Nov 20202:01 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
23rd Nov 20209:05 amRNSSecond Price Monitoring Extn
23rd Nov 20209:00 amRNSPrice Monitoring Extension
12th Oct 20206:10 pmRNSHolding(s) in Company
8th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
6th Oct 20207:00 amRNSHolding(s) in Company
5th Oct 20207:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.